Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI
Status
Conditions
Details and patient eligibility
About
The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic,which provide effective suggestions and strategies for emergency and severe treatment.
Full description
The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. The patients' prognosis is poor because the epidemic situation runs on medical resources, delays the diagnosis and treatment of other diseases such as cardiovascular diseases, and the patients' willingness to see a doctor is reduced. In particular, the delay in the treatment of STEMI, which needs PCI treatment, will cause more damage to the patients. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic. In this study, STEMI patients who experienced emergency PCI treatment after the covid-19 outbreak in 2020 were included, and compared with the data of the same period in 2019,we will analyze the pre hospital treatment time, vascular opening time,and the major cardiovascular adverse events, which provide effective suggestions and strategies for emergency and severe treatment.
Enrollment
Sex
Volunteers
Inclusion criteria
- Continuous inclusion of patients with definite diagnosis of acute ST segment elevation myocardial infarction and emergency PCI intervention.
Exclusion criteria
- Febrile patients, patients with severe infection,
- ST segment elevation myocardial infarction during hospitalization,
- Patients who could not cooperate with each other.
Trial design
200 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Hongwei Li, doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal